Radiochemist Erik de Blois pioneers with a radioactive medicine
Radiochemist Erik de Blois did not shy away from the great technical challenges of working with an α-emitter in a clinical environment under GMP conditions, resulting in the first phase 1 study with a radioactive medicine. ‘I have a practical mind.’
Want to read more?
Create a free account today!
- Gain access to all our content on chemistry, life sciences and process technology;
- Get our weekly newsletter so you never miss a story.
As a member of the KNCV, KVCV, NBV, or NVBMB you have unlimited access. Log in here.
